PDCD1 and melanoma: CD8+PD-1+ neoantigen-specific lymphocytes detected in the peripheral blood in melanoma patients resembled infiltrating CD8+PD-1+ cells in their tumors, implying that vaccine-induced CD8+PD-1+ lymphocytes could also traffic into the tumors [74].